Isleworth Healthcare Acquisition Corp. (ISLE)

NASDAQ: ISLE · IEX Real-Time Price · USD
+0.01 (0.10%)
Jun 24, 2022 3:59 PM EDT - Market closed
Market Cap 260.60M
Revenue (ttm) n/a
Net Income (ttm) 4.15M
Shares Out 26.19M
EPS (ttm) 0.16
PE Ratio 62.97
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 78,078
Open 9.94
Previous Close 9.94
Day's Range 9.94 - 9.95
52-Week Range 9.67 - 9.95
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About ISLE

Isleworth Healthcare Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire a business in the biopharmaceutical or medical technology/device industries. The company was incorporated in 2020 and is based in Saint Petersburg, Florida. [Read more...]

Industry Blank Check / SPAC
IPO Date Feb 25, 2021
Country United States
Stock Exchange NASDAQ
Ticker Symbol ISLE
Full Company Profile


Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK™ Cell Engager antibody at EHA 2022 Con...

Data supports further development of CYT-338 in relapsed/refractory multiple myeloma AVENTURA, Fla. and NATICK, Mass.

Isleworth Healthcare Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report

ST. PETERSBURG, Fla., June 3, 2021 /PRNewswire/ -- Isleworth Healthcare Acquisition Corp. (NASDAQ: ISLE) (the "Company") announced today announced that on May 28, 2021 it received a notice ("Notice") fr...

Isleworth Healthcare Acquisition Corp. Announces Upcoming Automatic Unit Separation

ST. PETERSBURG, Fla., March 25, 2021 /PRNewswire/ -- Isleworth Healthcare Acquisition Corp. (NASDAQ: ISLEU) (the "Company") announced today that, on March 29, 2021, the Company's units will no longer tr...